Aug 28, 2019 4:05 pm EDT Acasti Pharma Announces the Election of Its Directors, Amendments to Its Stock Option and Equity Incentive Plans and Other Related Matters Approved at Its AGM
Aug 9, 2019 8:00 am EDT Acasti Pharma Co-Founder, Chief Operating and Scientific Officer to Participate on Lipid Panel at the 2019 BTIG Biotechnology Conference
Jul 25, 2019 3:42 pm EDT Acasti Pharma Comments on Trading Activity and Reaffirms No Plans to Raise Capital
Jun 24, 2019 9:00 am EDT Acasti Pharma Awarded Notice of Allowance for a Second Patent in China Covering CaPre’s Omega-3 Phospholipid Composition
Jun 4, 2019 9:15 am EDT Acasti Pharma Announces TRILOGY 2 Trial Has Achieved its 100% Patient Randomization Target in Patients with Severe Hypertriglyceridemia
May 23, 2019 5:00 pm EDT Acasti Issues Shares in Settlement of Claims with Former Chief Executive Officer